Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
International Journal of Immunopharmacology|January 1, 1990
Effects of procainamide hydroxylamine on generation of reactive oxygen species by macrophages and production of cytokinesL E Adams, S M Roberts, J M Carter, et al.
Molecular Biology of the Cell|February 27, 2020
DYRK kinase Pom1 drives F-BAR protein Cdc15 from the membrane to promote medial divisionRahul Bhattacharjee, MariaSanta C Mangione, Marcin Wos, et al.
Arthritis and Rheumatism|March 17, 2004
Family study of fibromyalgiaLesley M Arnold, James I Hudson, Evelyn V Hess, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 7, 2010
Combining gemcitabine, oxaliplatin and capecitabine (GEMOXEL) for patients with advanced pancreatic carcinoma (APC): a phase I/II trialV Hess, S Pratsch, S Potthast, et al.
British Journal of Cancer|March 20, 2008
Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancerD Koeberle, R Burkhard, R von Moos, et al.
The Journal of Hand Surgery|June 8, 2015
A Mechanical Evaluation of Zone II Flexor Tendon Repair Using a Knotless Barbed Suture Versus a Traditional Braided SutureAniruddh N Nayak, Dzi-Viet Nguyen, Robert C Brabender, et al.
Arthritis and Rheumatism|March 30, 2007
Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trialLesley M Arnold, Don L Goldenberg, Sharon B Stanford, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2009
Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02)T Ruhstaller, L Widmer, J C Schuller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 20, 2008
Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKKM Borner, D Koeberle, R Von Moos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 11, 2018
Neoadjuvant chemotherapy followed by chemoradiation and surgery with and without cetuximab in patients with resectable esophageal cancer: a randomized, open-label, phase III trial (SAKK 75/08)T Ruhstaller, P Thuss-Patience, S Hayoz, et al.
Pageof 14